Lazard Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17
Closed 2320
2024
Q4
$0 Sell
17
-1
-6% -$9 ﹤0.01% 2294
2024
Q3
$0 Sell
18
-249
-93% -$4.14K ﹤0.01% 2271
2024
Q2
$4K Sell
267
-492
-65% -$9.86K ﹤0.01% 2066
2024
Q1
$19K Buy
759
+416
+121% +$10.7K ﹤0.01% 1844
2023
Q4
$9K Sell
343
-20
-6% -$1.22K ﹤0.01% 2100
2023
Q3
$21K Buy
363
+17
+5% +$1.19K ﹤0.01% 2086
2023
Q2
$22K Buy
346
+11
+3% +$805 ﹤0.01% 2078
2023
Q1
$20K Buy
335
+193
+136% +$22K ﹤0.01% 2051
2022
Q4
$19K Sell
142
-40
-22% -$5.63K ﹤0.01% 2134
2022
Q3
$22K Buy
182
+1
+0.6% +$113 ﹤0.01% 2072
2022
Q2
$14K Buy
181
+7
+4% +$543 ﹤0.01% 2178
2022
Q1
$16K Sell
174
-286
-62% -$37.7K ﹤0.01% 2098
2021
Q4
$91K Buy
460
+300
+188% +$70.8K ﹤0.01% 1477
2021
Q3
$39K Sell
160
-77
-32% -$22K ﹤0.01% 1790
2021
Q2
$97K Buy
237
+232
+4,640% +$91.9K ﹤0.01% 1353
2021
Q1
$1K Hold
5
﹤0.01% 1824
2020
Q4
$2K Sell
5
-3
-38% -$1.9K ﹤0.01% 1803
2020
Q3
$5K Sell
8
-97
-92% -$75.6K ﹤0.01% 1537
2020
Q2
$82K Buy
+105
New +$79.2K ﹤0.01% 1066
2019
Q4
Sell
-2
Closed -$2K 1535
2019
Q3
$2K Buy
+2
New +$3.05K ﹤0.01% 1389
2015
Q4
Sell
-52
Closed -$58K 1104
2015
Q3
$58K Buy
52
+7
+16% +$12.8K ﹤0.01% 915
2015
Q2
$97K Sell
45
-2
-4% -$4.07K ﹤0.01% 919
2015
Q1
$74K Sell
47
-322
-87% -$425K ﹤0.01% 949
2014
Q4
$437K Buy
+369
New +$247K ﹤0.01% 834

Other funds holding BLUE

Lazard Asset Management's BLUE Position: Q1 2025 in Review

Lazard Asset Management sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 17 shares.

Lazard Asset Management first reported a position in BLUE in Q4 2014 and held it in 24 quarters. The position peaked at $437K in Q4 2014. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Lazard Asset Management reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 17 bluebird bio shares in Q1 2025.
  • Lazard Asset Management first reported a position in bluebird bio in Q4 2014 and held it in 24 quarters.
  • Lazard Asset Management's bluebird bio position peaked at $437K in Q4 2014.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.